Cooperstown

Shutout! The Baseball Writers Association of America fails to elect anyone to the Hall of Fame

185 Comments

It’s possible that this year’s Hall of Fame ballot was the most stacked in the history of the institution.  It contained the all-time home run leader. It contained a seven-time Cy Young award winner who may have been the best pitcher in baseball history since the deadball era. It contained the best hitting catcher of all time. It contained a middle infielder who got to 3,000 hits while flashing superior defense and power. It sported a 609-home run hitter a 583-home run hitter, the second best leadoff hitter in the history of the game and at least five others who, had they been inducted, would not be close to the worst players to make the Hall of Fame.

And none of them got in. Not a one. For the first time since 1996, all candidates on the ballot failed to receive the requisite 75% required for induction.  The leading vote getter was Craig Biggio, who received 68% of the vote. Jack Morris received 67.7%, Jeff Bagwell received 59.6% of the vote, Mike Piazza 57.8% and Tim Raines at 52.2%. No other player received more than 50% of the vote. Roger Clemens received 37.6% of the vote and Barry Bonds received 36.2%. Each of those last two received totals far below even the most pessimistic predictions. The full results can be seen here.

The biggest takeaway from all of this: the Baseball Writers Association of America has, for the first time, unequivocally decided that the use of performance enhancing drugs is a disqualifier for induction to the Hall of Fame. It was suspected that this was the case given Mark McGwire and Rafael Palmeiro falling short in previous years, but there are some reasonable non-PED arguments against those fellows’ candidacies.  Not so with Bonds and Clemens. They were so good and so accomplished that, to paraphrase Bill James, you could cut them in half and have two hall of famers each. Maybe three, actually. Their exclusion is solely because a large portion of the electorate believes that one cannot take steroids and call Cooperstown home.

Which, while understandable, flies in the face of baseball history. There are almost certainly already steroids users in the Hall of Fame. Indeed, Hall of Fame voter and Washington Post columnist Thomas Boswell said on camera, in Ken Burns’ “Tenth Inning” that he witnessed a current Hall of Famer taking steroids during his playing career. Maybe his fellow voters ignored him. Maybe, since that player’s induction, whoever he is, their attitudes have changed. Either way, there is certainly now a historical inconsistency baked into the Hall of Fame.  And in no event can anyone who applauds today’s voting results do so on the basis of the Hall of Fame maintaining its purity, for its purity is pure fantasy.

But just as the BBWAA has now clearly stated that drug users are not wanted in the Hall of Fame, it has apparently likewise erected a near-impossible hurdle for those not associated with PEDs to bound, regardless of their merits.

Craig Biggio had 3,000 hits. Tim Raines was one of the best players of the 1980s. Curt Schilling has three World Series rings, was dominant in the playoffs, and was one of the best pitchers in all of baseball for several years when being a pitcher in baseball was about as hard as it has ever been.  While I disagree that we should keep the PED players out, I at least understand the impulse. What’s the point of keeping out guys like Biggio, Raines and Schilling? What’s the point of the Hall of Fame if no one can get in in a year as talent-rich as this one?

But that’s where we are. Not one of the players on the ballot made it in. The induction ceremony in Cooperstown, New York this summer will honor three men — Hank O’Day, Jacob Ruppert, and Deacon White — who were elected by the Veterans Committee last month.  All three of those men have been dead since the 1930s, so I don’t presume it will be a joyful gathering of family and friends reminiscing about their storied pasts. It’ll be more like a memorial service.

Which is somewhat appropriate given that, with their votes, the current electorate is, in this writer’s view, hastening the Hall of Fame to its doom.

Jacob deGrom open to extension with Mets

New York Mets starting pitcher Jacob deGrom talks during media day for the Major League Baseball World Series against the Kansas City Royals Monday, Oct. 26, 2015, in Kansas City, Mo. (AP Photo/Charlie Riedel)
AP Photo/Charlie Riedel
1 Comment

The Mets are currently enjoying the spoils of the best young rotation in the game, but the big question is whether this is just a brief window or the start of sustained success. Given the huge prices on the free agent market, it’s going to be next to impossible to keep the band together, but at least one member of the rotation is open to sticking around for the long-term.

While there haven’t been any talks yet, All-Star right-hander Jacob deGrom told Kevin Kernan of the New York Post that he could see himself discussing an extension with the Mets.

“I’m a little bit older, so I might be more willing to do something like that,’’ deGrom told The Post at Mets pre-camp. “You just have to look at what is fair so both sides get a decent deal. It’s something I’d have to look into and make sure I agree with it.’’

It makes sense from deGrom’s perspective. He broke into the majors later than most prospects, so he’ll be 28 this June. Depending on whether he qualifies as a Super Two, he’ll be arbitration-eligible for the first time after either 2016 or 2017. Either way, he’s under team control through 2020, which means that he’s currently on track to hit free agency after his age-32 season. The market might not be kind to him even if he manages to stay healthy, so it could behoove him to get as much guaranteed money as possible right now. The Mets could always decide to play things year-to-year, but perhaps deGrom would be willing to settle for a discount in order to get them to buy out a free agent year or two. It’s a really interesting situation to think about, but odds are the two sides will wait on contract talks until he’s arbitration-eligible for the first time.

DeGrom owns a 2.61 ERA in 52 starts over his first two seasons in the majors. Among starters, only Zack Greinke, Jake Arrieta, and Clayton Kershaw have a lower ERA since the start of 2014.

Royals, Mike Moustakas avoid arbitration with two-year deal

Kansas City Royals' Mike Moustakas celebrates after hitting an RBI single against the Toronto Blue Jays during the eighth inning in Game 2 of baseball's American League Championship Seriesagainst the Toronto Blue Jays  on Saturday, Oct. 17, 2015, in Kansas City, Mo. (Nathan Denette/The Canadian Press via AP) MANDATORY CREDIT
Nathan Denette/The Canadian Press via AP
1 Comment

The Royals and third baseman Mike Moustakas have avoided arbitration by agreeing to a two-year, $14.3 million deal, reports Jon Heyman of MLB Network.

The deal, which was initially discussed last month, buys out Moustakas’ final two years of arbitration. Jeffrey Flanagan of MLB.com reports that it’s believed he’ll make $5.6 million in 2016 and $8.7 million in 2017.

The 27-year-old Moustakas posted an underwhelming .668 OPS over his first four seasons in the majors, but he enjoyed a big postseason in 2014 before breaking out last season by batting .284/.348/.470 with 22 home runs and 82 RBI.

Report: Rays having “advanced talks” with free agent reliever Tommy Hunter

Baltimore Orioles relief pitcher Tommy Hunter throws to the Miami Marlins during the seventh inning of a baseball game in Miami, Friday, May 22, 2015. (AP Photo/J Pat Carter)
AP Photo/J Pat Carter
1 Comment

ESPN’s Jerry Crasnick reported this morning that free agent reliever Tommy Hunter required core muscle repair surgery earlier this offseason. Coming off a disappointing 2015, it’s understandable why he’s still on the market, but it sounds like he has at least one significant lead.

Marc Topkin of the Tampa Bay Times hears that the Rays are having “advanced talks” with Hunter as they attempt to add an experienced arm to their bullpen. Nothing is considered close and Hunter is also talking to other clubs. Meanwhile, the Rays have been in touch with veteran reliever Ryan Webb while monitoring the trade market.

Hunter posted a 2.88 ERA as a late-inning arm from 2013-2014, but he compiled a mediocre 4.18 ERA over 58 appearances last season between the Orioles and Cubs. On the bright side, his velocity has held steady and his control is still very good. Despite the down year and core muscle surgery, Topkin writes that Hunter may be holding out for a multi-year deal.

Pirates sign left-hander Cory Luebke

Cory Luebke Getty
Photo by Doug Pensinger/Getty Images
Leave a comment

Eric O'Flaherty wasn’t the only reclamation project added by the Pirates today, as the club also announced that they have signed left-hander Cory Luebke to a minor league contract with an invitation to spring training.

Luebke once looked like a solid rotation piece for the Padres, but he hasn’t thrown a pitch in the majors since April 27, 2012. He’s undergone a pair of Tommy John surgeries since. Now 30 years old, he logged seven innings in the minors last season before requiring a procedure to remove loose bodies around a nerve in his forearm. The Padres cut ties with him in November after declining a $7.5 million club option for 2016.

It’s hard to count on much from Luebke at this point, but he told Adam Berry of MLB.com that he feels healthy and hopes to compete for a bullpen job in the spring.